Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $115
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $113 to $115.
Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $113 to $115.